On Feb. 4, 2017, NCATS hosted another Assay Guidance Workshop for High-Throughput Screening and Lead Discovery. The session took place at the Society for Laboratory Automation and Screening’s annual international conference, held this year in Washington, D.C. More than 30 industry and academic researchers from nine countries and 12 U.S. states participated in the workshop, and nine Assay Guidance Manual editors covered a range of concepts critical for preclinical drug discovery. Open discussion featured topics including reproducible and robust methodologies, reagent validation, and statistical concepts for data analysis and assay interpretation. Plans for the next workshop are underway.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- National COVID Cohort Collaborative (N3C)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- News & Media
- Stories & Publications
- NCATS E-Newsletter
- Past E-Newsletter Issues
- NCATS Hosts Assay Guidance Workshop
NCATS Hosts Assay Guidance Workshop
- Funding & Notices
-